Membrane/NN
Proteins/NNS
Involved/JJ
in/IN
Epithelial-Mesenchymal/JJ
Transition/NN
and/CC
Tumor/NN
Invasion/NN
:/:
Studies/NNS
on/IN
TMPRSS4/NN
and/CC
TM4SF5/NN
./.
====================
The/DT
epithelial-mesenchymal/JJ
transition/NN
(/(
EMT/NN
)/)
is/VBZ
one/CD
mechanism/NN
by/IN
which/WDT
cells/NNS
with/IN
mesenchymal/JJ
features/NNS
can/MD
be/VB
generated/VBN
and/CC
is/VBZ
a/DT
fundamental/JJ
event/NN
in/IN
morphogenesis/NN
./.
====================
Recently/RB
,/,
invasion/NN
and/CC
metastasis/NN
of/IN
cancer/NN
cells/NNS
from/IN
the/DT
primary/JJ
tumor/NN
are/VBP
now/RB
thought/VBN
to/TO
be/VB
initiated/VBN
by/IN
the/DT
developmental/JJ
process/NN
termed/VBN
the/DT
EMT/NN
,/,
whereby/RB
epithelial/JJ
cells/NNS
lose/VBP
cell/NN
polarity/NN
and/CC
cell-cell/JJ
interactions/NNS
,/,
and/CC
gain/NN
mesenchymal/JJ
phenotypes/NNS
with/IN
increased/VBN
migratory/JJ
and/CC
invasive/JJ
properties/NNS
./.
====================
The/DT
EMT/NN
is/VBZ
believed/VBN
to/TO
be/VB
an/DT
important/JJ
step/NN
in/IN
metastasis/NN
and/CC
is/VBZ
implicated/VBN
in/IN
cancer/NN
progression/NN
,/,
although/IN
the/DT
influence/NN
of/IN
the/DT
EMT/NN
in/IN
clinical/JJ
specimens/NNS
has/VBZ
been/VBN
debated/VBN
./.
====================
This/DT
review/NN
presents/VBZ
the/DT
recent/JJ
results/NNS
of/IN
two/CD
cell/NN
surface/NN
proteins/NNS
,/,
the/DT
functions/NNS
and/CC
underlying/VBG
mechanisms/NNS
of/IN
which/WDT
have/VBP
recently/RB
begun/VBN
to/TO
be/VB
demonstrated/VBN
,/,
as/IN
novel/JJ
regulators/NNS
of/IN
the/DT
molecular/JJ
networks/NNS
that/IN
induce/VBP
the/DT
EMT/NN
and/CC
cancer/NN
progression/NN
./.
====================
Metastasis/NN
is/VBZ
the/DT
leading/VBG
cause/VBP
of/IN
cancer-related/JJ
deaths/NNS
in/IN
most/JJS
cancer/NN
types/NNS
./.
====================
As/IN
an/DT
initial/JJ
step/NN
in/IN
cancer/NN
metastasis/NN
,/,
epithelial/JJ
tumor/NN
cells/NNS
in/IN
general/JJ
disseminate/NN
from/IN
a/DT
primary/JJ
solid/JJ
tumor/NN
mass/NN
and/CC
invade/VBP
into/IN
the/DT
surrounding/VBG
stromal/JJ
tissues/NNS
./.
====================
Invasion/NN
is/VBZ
enhanced/VBN
by/IN
tumor/NN
cell/NN
activation/NN
of/IN
the/DT
epithelial-mesenchymal/JJ
transition/NN
(/(
EMT/NN
)/)
[/(
1/CD
,/,
2/CD
,/,
3/CD
,/,
4/CD
]/)
./.
====================
The/DT
EMT/NN
is/VBZ
characterized/VBN
by/IN
the/DT
loss/NN
of/IN
epithelial/JJ
apicobasal/JJ
polarity/NN
and/CC
cell-cell/JJ
contacts/NNS
,/,
modulation/NN
of/IN
cell-matrix/JJ
adhesion/NN
,/,
enhanced/VBD
proteolytic/JJ
activity/NN
,/,
cytoskeletal/JJ
remodeling/NN
,/,
and/CC
acquisition/NN
of/IN
the/DT
ability/NN
to/TO
migrate/VB
and/CC
invade/VBP
the/DT
extracellular/JJ
matrix/NN
(/(
ECM/NN
)/)
[/(
1/CD
,/,
3/CD
]/)
./.
====================
During/IN
the/DT
EMT/NN
,/,
epithelial/JJ
cells/NNS
undergo/VBP
molecular/JJ
changes/NNS
;/:
epithelial/JJ
cells/NNS
gradually/RB
lose/VBP
their/PRP$
epithelial/JJ
markers/NNS
,/,
such/JJ
as/IN
E-cadherin/NN
,/,
ZO-1/NN
,/,
and/CC
cytokeratins/NNS
,/,
and/CC
concomitantly/RB
acquire/VBP
mesenchymal/JJ
markers/NNS
,/,
such/JJ
as/IN
vimentin/NN
,/,
fibronectin/NN
,/,
N-cadherin/NN
,/,
and/CC
alpha/NN
smooth/JJ
muscle/NN
actin/NN
[/(
1/CD
,/,
3/CD
]/)
./.
====================
The/DT
EMT/NN
plays/VBZ
a/DT
critical/JJ
role/NN
in/IN
the/DT
formation/NN
of/IN
various/JJ
tissues/NNS
and/CC
organs/NNS
,/,
such/JJ
as/IN
the/DT
mesoderm/JJ
,/,
neural/JJ
crest/VBP
,/,
heart/NN
,/,
secondary/JJ
palate/JJ
,/,
and/CC
peripheral/JJ
nervous/JJ
systems/NNS
,/,
during/IN
embryonic/JJ
development/NN
and/CC
wound/NN
healing/NN
in/IN
adult/JJ
organism/NN
[/(
2/CD
,/,
4/CD
]/)
./.
====================
Furthermore/RB
,/,
the/DT
EMT/NN
is/VBZ
implicated/VBN
in/IN
pathological/JJ
processes/NNS
,/,
such/JJ
as/IN
tumor/NN
cell/NN
invasion/NN
and/CC
metastasis/NN
and/CC
organ/NN
fibrosis/NN
[/(
2/CD
]/)
./.
====================
One/CD
of/IN
the/DT
hallmarks/NNS
of/IN
the/DT
EMT/NN
is/VBZ
the/DT
functional/JJ
loss/NN
of/IN
E-cadherin/NN
,/,
which/WDT
is/VBZ
currently/RB
thought/VBN
to/TO
be/VB
a/DT
metastasis/NN
suppressor/NN
[/(
5/CD
]/)
./.
====================
Downregulation/NN
of/IN
E-cadherin/NN
is/VBZ
usually/RB
mediated/VBN
by/IN
E-cadherin/NN
transcriptional/JJ
repressors/EMT-inducing/VBG
transcription/NN
factors/NNS
,/,
including/VBG
the/DT
Snail/NN
superfamily/RB
of/IN
zinc-finger/NN
factors/NNS
(/(
Snail/NN
and/CC
Slug/NN
)/)
,/,
the/DT
ZEB/NN
family/NN
(/(
ZEB1/NN
and/CC
ZEB2/NN
)/)
,/,
and/CC
basic/JJ
helix-loop-helix/JJ
factors/NNS
(/(
Twist1/NN
and/CC
E47/NN
)/)
,/,
which/WDT
have/VBP
been/VBN
associated/VBN
with/IN
tumor/NN
invasion/NN
and/CC
metastasis/NN
[/(
4/CD
,/,
5/CD
]/)
./.
====================
These/DT
factors/NNS
repress/VBP
transcription/NN
of/IN
E-cadherin/NN
by/IN
interacting/VBG
with/IN
proximal/JJ
E-box/NN
elements/NNS
in/IN
the/DT
E-cadherin/NN
promoter/NN
[/(
5/CD
]/)
./.
====================
In/IN
addition/NN
,/,
these/DT
E-cadherin/NN
repressors/NNS
may/MD
be/VB
directly/RB
or/CC
indirectly/RB
involved/VBN
in/IN
the/DT
upregulation/NN
of/IN
certain/JJ
mesenchymal/JJ
genes/NNS
[/(
5/CD
]/)
,/,
although/IN
the/DT
precise/JJ
mechanism/NN
of/IN
this/DT
regulation/NN
is/VBZ
largely/RB
unknown/JJ
./.
====================
The/DT
EMT/NN
is/VBZ
triggered/VBN
by/IN
soluble/JJ
growth/NN
factors/NNS
,/,
such/JJ
as/IN
members/NNS
of/IN
the/DT
transforming/VBG
growth/NN
factor-β/JJ
(/(
TGFβ/NN
)/)
and/CC
fibroblast/NN
growth/NN
factor/NN
families/NNS
,/,
epidermal/JJ
growth/NN
factor/NN
,/,
and/CC
hepatocyte/NN
growth/NN
factor/NN
(/(
HGF/NN
)/)
[/(
3/CD
,/,
4/CD
]/)
./.
====================
Subsequent/JJ
activation/NN
of/IN
receptor-mediated/JJ
signaling/NN
triggers/VBZ
the/DT
activation/NN
of/IN
intracellular/JJ
effector/NN
molecules/NNS
,/,
such/JJ
as/IN
members/NNS
of/IN
the/DT
small/JJ
GTPase/NN
family/NN
,/,
leading/VBG
to/TO
changes/NNS
in/IN
cytoskeletal/JJ
organization/NN
,/,
and/CC
also/RB
results/VBZ
in/IN
the/DT
activation/NN
of/IN
EMT-inducing/JJ
transcription/NN
factors/NNS
[/(
3/CD
,/,
4/CD
]/)
./.
====================
In/IN
addition/NN
,/,
components/NNS
of/IN
the/DT
ECM/NN
,/,
such/JJ
as/IN
collagen/NN
,/,
and/CC
activation/NN
of/IN
integrin/NN
co-receptors/NNS
are/VBP
also/RB
involved/VBN
in/IN
the/DT
EMT/NN
process/NN
[/(
3/CD
]/)
./.
====================
Certain/JJ
proteases/NNS
are/VBP
sufficient/JJ
to/TO
induce/VB
the/DT
EMT/NN
[/(
2/CD
]/)
;/:
for/IN
example/NN
,/,
matrix/NN
metalloproteinase-3/NN
triggers/VBZ
the/DT
EMT/NN
by/IN
increasing/VBG
the/DT
cellular/JJ
levels/NNS
of/IN
reactive/JJ
oxygen/NN
species/NNS
,/,
which/WDT
in/IN
turn/NN
induces/VBZ
Snail/JJ
expression/NN
[/(
6/CD
]/)
./.
====================
Recently/RB
,/,
microRNAs/NNS
(/(
miRs/NNS
)/)
have/VBP
been/VBN
identified/VBN
as/IN
a/DT
novel/JJ
class/NN
of/IN
EMT/NN
regulators/NNS
;/:
miRs/NNS
that/DT
negatively/RB
regulate/VB
the/DT
EMT/NN
include/VBP
miR-153/NN
,/,
-155/CD
,/,
-194/CD
,/,
-25/CD
,/,
-212/CD
,/,
and/CC
-200/CD
,/,
and/CC
miRs/NNS
that/DT
positively/RB
regulate/VBP
the/DT
EMT/NN
include/VBP
miR-29a/NNS
,/,
-103/107/CD
,/,
-150/CD
,/,
and/CC
-221/22/CD
[/(
7/CD
]/)
./.
====================
miRs/NNS
regulate/VBP
invasion/NN
and/CC
metastasis/NN
by/IN
targeting/VBG
the/DT
transcripts/NNS
of/IN
various/JJ
genes/NNS
involved/VBN
in/IN
the/DT
EMT/NN
event/NN
,/,
including/VBG
EMT-inducing/JJ
transcription/NN
factors/NNS
./.
====================
For/IN
example/NN
,/,
members/NNS
of/IN
the/DT
miR-200/NN
family/NN
are/VBP
negative/JJ
regulators/NNS
of/IN
the/DT
EMT/NN
and/CC
are/VBP
essential/JJ
for/IN
maintenance/NN
of/IN
the/DT
epithelial/JJ
status/NN
through/IN
the/DT
downregulation/NN
of/IN
ZEB1/NN
and/CC
ZEB2/NN
./.
====================
In/IN
turn/NN
,/,
miR-200/NN
members/NNS
are/VBP
transcriptionally/RB
repressed/VBN
by/IN
ZEB1/NN
and/CC
ZEB2/NN
,/,
thus/RB
establishing/VBG
a/DT
double-negative/JJ
feedback/NN
loop/NN
[/(
8/CD
]/)
./.
====================
The/DT
EMT/NN
was/VBD
recently/RB
shown/VBN
to/TO
be/VB
linked/VBN
to/TO
stemness/VB
and/CC
self-renewal/JJ
capacity/NN
[/(
9/CD
,/,
10/CD
]/)
./.
====================
In/IN
cases/NNS
of/IN
breast/NN
cancer/NN
stems/NNS
,/,
the/DT
linkage/NN
among/IN
EMT/NN
phenotype/NN
,/,
stemness/RB
,/,
and/CC
drug/NN
resistance/NN
has/VBZ
been/VBN
well/RB
studied/VBN
[/(
11/CD
]/)
./.
====================
Further/RB
,/,
epithelialmesenchymal/JJ
plasticity/NN
(/(
consisting/VBG
of/IN
EMT/NN
and/CC
MET/NN
)/)
is/VBZ
also/RB
described/VBN
in/IN
circulating/VBG
tumor/NN
cells/NNS
(/(
CTCs/NNS
)/)
[/(
12/CD
,/,
13/CD
,/,
14/CD
]/)
./.
====================
CTCs/NNS
with/IN
various/JJ
degrees/NNS
of/IN
EMT/NN
phenotypes/NNS
are/VBP
found/VBN
during/IN
breast/NN
cancer/NN
metastasis/NN
[/(
15/CD
]/)
./.
====================
Therefore/RB
,/,
CTCs/NNS
may/MD
involve/VB
self-renewal/JJ
capacity/NN
,/,
which/WDT
is/VBZ
linked/VBN
to/TO
the/DT
EMT/NN
,/,
during/IN
cancer/NN
metastasis/NN
[/(
16/CD
]/)
./.
====================
Introduction/NN
to/TO
type/NN
II/CD
transmembrane/JJ
serine/NN
proteases/NNS
====================
Dysregulation/NN
of/IN
proteases/NNS
is/VBZ
a/DT
hallmark/NN
of/IN
cancer/NN
progression/NN
;/:
thus/RB
,/,
proteases/NNS
in/IN
general/JJ
have/VBP
been/VBN
the/DT
subject/JJ
of/IN
numerous/JJ
cancer/NN
studies/NNS
./.
====================
Extracellular/JJ
proteolytic/JJ
enzymes/NNS
,/,
including/VBG
matrix/NN
metalloproteinases/NNS
(/(
MMPs/NNS
)/)
and/CC
serine/NN
proteases/NNS
,/,
contribute/VBP
to/TO
tumor/NN
cell/NN
invasion/NN
and/CC
metastasis/NN
through/IN
both/CC
direct/JJ
proteolytic/JJ
activity/NN
and/CC
the/DT
regulation/NN
of/IN
cellular/JJ
signaling/NN
and/CC
functions/NNS
[/(
17/CD
,/,
18/CD
,/,
19/CD
]/)
./.
====================
Most/JJS
members/NNS
of/IN
the/DT
serine/NN
protease/NN
family/NN
are/VBP
either/CC
secreted/VBN
or/CC
sequestered/VBN
in/IN
cytoplasmic/JJ
organelles/NNS
awaiting/VBG
signal-regulated/JJ
release/NN
./.
====================
Recently/RB
,/,
type/NN
II/CD
transmembrane/JJ
serine/NN
proteases/NNS
(/(
TTSPs/NNS
)/)
have/VBP
been/VBN
recognized/VBN
as/IN
a/DT
new/JJ
subfamily/RB
of/IN
serine/NN
proteases/NNS
that/IN
have/VBP
in/IN
common/JJ
an/DT
extracellular/JJ
proteolytic/JJ
domain/NN
,/,
a/DT
single-pass/JJ
transmembrane/JJ
domain/NN
,/,
a/DT
short/JJ
intracellular/JJ
domain/NN
,/,
and/CC
a/DT
variable-length/JJ
stem/NN
region/NN
containing/VBG
modular/JJ
structural/JJ
domains/NNS
[/(
20/CD
,/,
21/CD
,/,
22/CD
,/,
23/CD
,/,
24/CD
]/)
./.
====================
Enteropeptidase/NN
(/(
also/RB
known/VBN
as/IN
enterokinase/JJ
)/)
,/,
identified/VBD
over/IN
a/DT
century/JJ
ago/RB
due/JJ
to/TO
its/PRP$
pivotal/JJ
role/NN
in/IN
food/NN
digestion/NN
,/,
is/VBZ
the/DT
first/JJ
TTSP/NN
,/,
which/WDT
was/VBD
revealed/VBN
by/IN
molecular/JJ
cloning/NN
of/IN
the/DT
enteropeptidase/NN
cDNA/NN
two/CD
decades/NNS
ago/RB
[/(
25/CD
]/)
./.
====================
TMPRSS2/NN
,/,
human/JJ
airway/NN
trypsin-like/JJ
protease/NN
(/(
HAT/NN
)/)
,/,
corin/NN
,/,
and/CC
matriptase/NN
have/VBP
been/VBN
subsequently/RB
identified/VBN
as/IN
cell/NN
surface-associated/JJ
proteases/NNS
[/(
23/CD
,/,
24/CD
]/)
./.
====================
To/TO
date/NN
,/,
20/CD
TTSPs/NNS
have/VBP
been/VBN
identified/VBN
in/IN
mouse/NN
and/CC
humans/NNS
due/JJ
to/TO
the/DT
analysis/NN
of/IN
sequence/NN
data/NNS
from/IN
mammalian/JJ
genome/NN
projects/NNS
[/(
23/CD
]/)
./.
====================
Analysis/NN
of/IN
the/DT
tissue/NN
distribution/NN
of/IN
TTSPs/NNS
and/CC
gene/NN
targeting/VBG
in/IN
mice/NNS
of/IN
certain/JJ
TTSPs/NNS
suggested/VBD
that/IN
a/DT
significant/JJ
number/NN
of/IN
TTSPs/NNS
may/MD
have/VB
important/JJ
functions/NNS
in/IN
embryonic/JJ
development/NN
and/CC
homeostasis/NN
of/IN
mammalian/JJ
tissues/NNS
,/,
such/JJ
as/IN
heart/NN
,/,
skin/NN
,/,
inner/JJ
ear/JJ
,/,
placenta/NN
,/,
and/CC
digestive/JJ
tract/VBP
[/(
23/CD
,/,
24/CD
]/)
./.
====================
Most/JJS
TTSPs/NNS
are/VBP
overexpressed/VBN
in/IN
a/DT
variety/NN
of/IN
tumors/NNS
compared/VBN
to/TO
normal/JJ
tissues/NNS
,/,
implicating/VBG
their/PRP$
potential/JJ
as/IN
novel/JJ
markers/NNS
of/IN
tumor/NN
development/NN
and/CC
progression/NN
and/CC
possible/JJ
molecular/JJ
targets/NNS
for/IN
anti-cancer/JJ
therapeutics/NNS
[/(
23/CD
,/,
26/CD
]/)
./.
====================
Recently/RB
,/,
a/DT
number/NN
of/IN
works/NNS
have/VBP
focused/VBN
on/IN
the/DT
evaluation/NN
of/IN
the/DT
expression/NN
of/IN
individual/JJ
TTSPs/NNS
during/IN
tumor/NN
progression/NN
and/CC
on/IN
the/DT
investigation/NN
of/IN
the/DT
potential/JJ
roles/NNS
of/IN
these/DT
proteases/NNS
in/IN
tumor/NN
cell/NN
proliferation/NN
,/,
migration/NN
,/,
and/CC
invasion/NN
[/(
23/CD
,/,
27/CD
]/)
./.
====================
TMPRSS4/CD
in/IN
cancer/NN
====================
TMPRSS4/CD
(/(
gene/NN
ID/NN
,/,
56649/CD
;/:
chromosomal/JJ
location/NN
,/,
11q23.3/CD
)/)
,/,
initially/RB
referred/VBN
to/TO
as/IN
TMPRSS3/NN
,/,
was/VBD
originally/RB
identified/VBN
as/IN
a/DT
gene/NN
expressed/VBD
in/IN
most/JJS
pancreatic/JJ
cancer/NN
tissues/NNS
but/CC
not/RB
in/IN
the/DT
normal/JJ
pancreas/NN
or/CC
chronic/JJ
pancreatitis/NN
[/(
28/CD
]/)
./.
====================
To/TO
date/NN
,/,
7/CD
isoforms/NNS
have/VBP
been/VBN
reported/VBN
./.
====================
The/DT
deduced/VBN
sequence/NN
of/IN
437/CD
amino/NN
acids/NNS
of/IN
the/DT
longest/JJS
isoform/NN
(/(
isoform/NN
1/CD
)/)
contains/VBZ
a/DT
serine/NN
protease/NN
domain/NN
with/IN
putative/JJ
trypsin-like/JJ
activity/NN
and/CC
a/DT
transmembrane/JJ
domain/NN
[/(
28/CD
]/)
./.
====================
In/IN
human/JJ
,/,
TMPRSS4/NN
mRNA/NN
was/VBD
detected/VBN
in/IN
bladder/JJ
,/,
esophagus/FW
,/,
stomach/NN
,/,
small/JJ
intestine/NN
,/,
colon/NN
,/,
and/CC
kidney/NN
[/(
28/CD
]/)
,/,
although/IN
the/DT
physiological/JJ
roles/NNS
of/IN
TMPRSS4/NN
remain/VBP
unknown/JJ
./.
====================
Furthermore/RB
,/,
TMPRSS4/NN
expression/NN
was/VBD
upregulated/VBN
in/IN
malignant/JJ
compared/VBN
to/TO
benign/JJ
thyroid/NN
neoplasm/NN
and/CC
was/VBD
suggested/VBN
as/IN
both/CC
a/DT
diagnostic/JJ
and/CC
prognostic/JJ
marker/NN
[/(
29/CD
,/,
30/CD
]/)
./.
====================
TMPRSS4/CD
was/VBD
associated/VBN
with/IN
poor/JJ
prognosis/NN
in/IN
non-small-cell/JJ
lung/NN
cancer/NN
(/(
NSCLC/NN
)/)
with/IN
squamous/JJ
cell/NN
histology/NN
[/(
31/CD
]/)
,/,
triple-negative/JJ
breast/NN
cancer/NN
[/(
32/CD
]/)
,/,
cervical/JJ
cancer/NN
[/(
33/CD
]/)
,/,
and/CC
gastric/JJ
cancer/NN
patients/NNS
[/(
34/CD
]/)
./.
====================
Kim/NN
et/FW
al/JJ
./.
====================
[/(
35/CD
]/)
reported/VBD
that/IN
TMPRSS4/NN
mRNA/NN
levels/NNS
were/VBD
upregulated/VBN
in/IN
colorectal/JJ
cancer/NN
tissues/NNS
versus/CC
adjacent/JJ
normal/JJ
mucosa/NN
./.
====================
The/DT
authors/NNS
also/RB
reported/VBD
that/IN
TMPRSS4/NN
protein/NN
expression/NN
was/VBD
significantly/RB
higher/JJR
in/IN
human/JJ
colorectal/JJ
cancer/NN
tissues/NNS
from/IN
advanced/JJ
stages/NNS
(/(
52.5/CD
%/NN
and/CC
50.0/CD
%/NN
of/IN
stages/NNS
III/CD
and/CC
IV/CD
,/,
respectively/RB
)/)
than/IN
in/IN
that/DT
of/IN
early/JJ
stage/NN
(/(
6.3/CD
%/NN
in/IN
stage/NN
I/CD
)/)
,/,
suggesting/VBG
that/IN
TMPRSS4/NN
may/MD
play/VB
a/DT
role/NN
in/IN
the/DT
progression/NN
of/IN
non-invasive/JJ
tumors/NNS
to/TO
invasive/JJ
malignancies/NNS
[/(
35/CD
]/)
./.
====================
Jia/NN
et/FW
al/JJ
./.
====================
[/(
36/CD
]/)
showed/VBD
that/IN
the/DT
inhibitory/JJ
tripeptide/NN
tyroserleutide/NN
led/VBD
to/TO
downregulation/NN
of/IN
TMPRSS4/NN
in/IN
hepatocellular/JJ
carcinoma/NN
(/(
HCC/NN
)/)
,/,
thereby/RB
reducing/VBG
the/DT
invasion/NN
and/CC
metastasis/NN
of/IN
HCC/NN
induced/VBD
by/IN
irradiation/NN
./.
====================
Taken/VBN
together/RB
,/,
TMPRSS4/NN
may/MD
be/VB
a/DT
novel/JJ
biomarker/NN
for/IN
the/DT
prognosis/NN
of/IN
certain/JJ
types/NNS
of/IN
cancers/NNS
and/CC
could/MD
be/VB
employed/VBN
for/IN
diagnostics/NNS
and/CC
therapeutics/NNS
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
the/DT
mechanism/NN
by/IN
which/WDT
TMPRSS4/NN
expression/NN
is/VBZ
modulated/VBN
has/VBZ
not/RB
been/VBN
well/RB
characterized/VBN
./.
====================
Recently/RB
,/,
Nguyen/JJ
et/FW
al/JJ
./.
====================
[/(
37/CD
]/)
reported/VBD
that/IN
TMPRSS4/NN
was/VBD
increased/VBN
in/IN
NSCLC/NN
cells/NNS
under/IN
hypoxic/JJ
conditions/NNS
,/,
suggesting/VBG
that/IN
hypoxia/NN
within/IN
the/DT
tumor/NN
microenvironment/NN
may/MD
upregulate/VB
TMPRSS4/NN
expression/NN
./.
====================
Function/NN
of/IN
TMPRSS4/NN
in/IN
the/DT
regulation/NN
of/IN
EMT/NN
and/CC
invasion/NN
====================
In/IN
colon/NN
cancer/NN
cells/NNS
,/,
TMPRSS4/NN
induces/VBZ
downregulation/NN
of/IN
E-cadherin/NN
and/CC
leads/VBZ
to/TO
EMT/NN
events/NNS
,/,
accompanying/VBG
morphological/JJ
changes/NNS
and/CC
actin/NN
reorganization/NN
[/(
38/CD
]/)
./.
====================
Suppression/NN
of/IN
TMPRSS4/NN
by/IN
siRNA/JJ
reduces/VBZ
cell/NN
invasion/NN
in/IN
colon/NN
and/CC
lung/NN
cancer/NN
cells/NNS
,/,
while/IN
overexpression/NN
TMPRSS4/NN
induces/VBZ
migration/NN
,/,
invasion/NN
,/,
and/CC
metastasis/NN
[/(
38/CD
]/)
./.
====================
Attachment/JJ
and/CC
spreading/NN
of/IN
cells/NNS
on/IN
the/DT
ECM/NN
,/,
with/IN
concomitant/JJ
formation/NN
of/IN
stress/NN
fibers/NNS
and/CC
focal/JJ
adhesions/NNS
,/,
is/VBZ
a/DT
prerequisite/NN
for/IN
cell/NN
migration/NN
./.
====================
TMPRSS4/CD
also/RB
modulates/VBZ
cell-matrix/JJ
adhesion/NN
and/CC
cell/NN
spreading/NN
mainly/RB
through/IN
modulation/NN
of/IN
integrins/NNS
,/,
such/JJ
as/IN
α5β1/RB
,/,
which/WDT
has/VBZ
been/VBN
centrally/RB
implicated/VBN
in/IN
the/DT
EMT/NN
and/CC
cell/NN
motility/NN
[/(
39/CD
,/,
40/CD
]/)
,/,
which/WDT
probably/RB
contributes/VBZ
to/TO
enhanced/VBN
motility/NN
and/CC
invasiveness/RB
./.
====================
One/CD
of/IN
the/DT
molecular/JJ
mechanisms/NNS
by/IN
which/WDT
TMPRSS4/NN
mediates/VBZ
the/DT
EMT/NN
and/CC
invasiveness/RB
in/IN
tumor/NN
cells/NNS
is/VBZ
that/IN
TMPRSS4/NN
mediates/VBZ
focal/JJ
adhesion/NN
kinase/NN
(/(
FAK/NN
)/)
signaling/NN
pathway/NN
activation/NN
and/CC
extracellular/JJ
signal-regulated/JJ
kinase/NN
(/(
ERK/NN
)/)
activation/NN
,/,
mainly/RB
through/IN
integrin/NN
α5/NN
upregulation/NN
,/,
leading/VBG
to/TO
the/DT
EMT/NN
and/CC
invasiveness/RB
./.
====================
Furthermore/RB
,/,
TMPRSS4/NN
overexpression/NN
in/IN
human/JJ
colorectal/JJ
cancer/NN
tissues/NNS
positively/RB
correlates/VBZ
with/IN
enhanced/VBN
expression/NN
of/IN
integrin/NN
α5/NN
and/CC
inversely/RB
correlates/VBZ
with/IN
E-cadherin/NN
expression/NN
,/,
confirming/VBG
that/IN
TMPRSS4/NN
modulates/VBZ
expression/NN
of/IN
EMT/NN
markers/NNS
./.
====================
Recently/RB
,/,
Larzabal/JJ
et/FW
al/JJ
./.
====================
[/(
41/CD
]/)
reported/VBD
that/IN
miR-205/NN
is/VBZ
involved/VBN
in/IN
TMPRSS4-induced/JJ
integrin/NN
α5/NN
expression/NN
in/IN
NSCLC/NN
cells/NNS
./.
====================
To/TO
further/RBR
implicate/VBP
TMPRSS4/NN
in/IN
the/DT
EMT/NN
,/,
Cheng/JJ
et/FW
al/JJ
./.
====================
[/(
42/CD
]/)
suggested/VBD
that/IN
interactions/NNS
between/IN
HGF/NN
activator/NN
inhibitor/NN
(/(
HAI-1/NN
)/)
and/CC
TMPRSS4/NN
contribute/VBP
to/TO
EMT/NN
events/NNS
,/,
including/VBG
E-cadherin/NN
reduction/NN
and/CC
morphological/JJ
changes/NNS
in/IN
pancreatic/JJ
cancer/NN
cells/NNS
./.
====================
In/IN
addition/NN
,/,
TMPRSS4-induced/JJ
E-cadherin/NN
reduction/NN
and/CC
EMT/NN
play/VBP
a/DT
critical/JJ
role/NN
in/IN
radiation-induced/JJ
long-term/JJ
metastasis/NN
of/IN
residual/JJ
HCC/NN
in/IN
nude/JJ
mice/NNS
[/(
43/CD
]/)
./.
====================
Interaction/NN
of/IN
TMPRSS4/NN
and/CC
integrin/NN
α5/NN
,/,
based/VBN
on/IN
the/DT
observation/NN
that/IN
TMPRSS4/NN
partially/RB
interacts/VBZ
with/IN
integrin/NN
α5/NN
under/IN
certain/JJ
coimmunoprecipitation/NN
conditions/NNS
in/IN
a/DT
cell/NN
line-dependent/JJ
manner/NN
[/(
35/CD
]/)
(/(
Kim/NN
S/NN
,/,
unpublished/JJ
observation/NN
)/)
,/,
suggests/VBZ
the/DT
possibility/NN
that/IN
TMPRSS4/NN
may/MD
modulate/VB
or/CC
participate/VB
in/IN
the/DT
interaction/NN
of/IN
integrin/NN
and/CC
other/JJ
cell/NN
surface/NN
proteins/NNS
(/(
for/IN
example/NN
,/,
tetraspanin/NN
,/,
receptor/NN
tyrosine/NN
kinases/NNS
,/,
etc/JJ
./.
====================
)/)
,/,
leading/VBG
to/TO
subsequent/JJ
signaling/NN
transduction/NN
activation/NN
./.
====================
In/IN
fact/NN
,/,
TMPRSS4/NN
can/MD
interact/VB
with/IN
urokinase/NN
plasminogen/NN
activator/NN
receptor/NN
(/(
uPAR/NN
;/:
CD87/NN
)/)
[/(
44/CD
]/)
,/,
which/WDT
can/MD
induce/VB
the/DT
EMT/NN
in/IN
hypoxic/JJ
breast/NN
cancer/NN
cells/NNS
[/(
45/CD
]/)
,/,
although/IN
it/PRP
is/VBZ
not/RB
clear/JJ
whether/IN
TMPRSS4/NN
interacts/VBZ
with/IN
uPAR/NN
directly/RB
or/CC
via/IN
integrin/NN
(/(
s/NNS
)/)
./.
====================
Loss/NN
or/CC
reduction/NN
of/IN
E-cadherin/NN
expression/NN
is/VBZ
a/DT
well-known/JJ
hallmark/NN
of/IN
the/DT
EMT/NN
and/CC
correlates/VBZ
positively/RB
with/IN
tumor/NN
cell/NN
invasion/NN
and/CC
metastasis/NN
[/(
3/CD
]/)
./.
====================
TMPRSS4/CD
appears/VBZ
to/TO
modulate/VB
SIP1/ZEB2/NN
expression/NN
,/,
based/VBN
on/IN
the/DT
observation/NN
that/IN
SIP1/NN
mRNA/NN
is/VBZ
upregulated/VBN
in/IN
TMPRSS4-overexpressing/JJ
colon/NN
cancer/NN
cells/NNS
,/,
although/IN
induction/NN
of/IN
SIP1/NN
at/IN
the/DT
protein/NN
level/NN
remains/VBZ
to/TO
be/VB
determined/VBN
./.
====================
Therefore/RB
,/,
it/PRP
is/VBZ
possible/JJ
that/IN
SIP1/NN
mediates/VBZ
TMPRSS4-induced/JJ
EMT/NN
events/NNS
,/,
including/VBG
E-cadherin/NN
reduction/NN
./.
====================
Several/JJ
studies/NNS
have/VBP
shown/VBN
that/IN
suppression/NN
of/IN
high/JJ
endogenous/JJ
E-cadherin/NN
expression/NN
renders/VBZ
non-invasive/JJ
cells/NNS
partially/RB
invasive/JJ
[/(
46/CD
]/)
,/,
whereas/IN
reconstitution/NN
of/IN
E-cadherin/NN
results/NNS
in/IN
tumor/NN
cell/NN
reversion/NN
from/IN
an/DT
invasive/JJ
mesenchymal/JJ
phenotype/NN
to/TO
a/DT
benign/JJ
epithelial/JJ
phenotype/NN
[/(
46/CD
,/,
47/CD
]/)
./.
====================
In/IN
contrast/NN
,/,
other/JJ
studies/NNS
have/VBP
shown/VBN
that/IN
ectopic/JJ
expression/NN
of/IN
E-cadherin/NN
could/MD
not/RB
reverse/JJ
EMT/NN
phenotypes/NNS
induced/VBD
by/IN
the/DT
transcription/NN
factor/NN
Twist1/NN
[/(
10/CD
]/)
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
downregulation/NN
of/IN
E-cadherin/NN
was/VBD
required/VBN
for/IN
TMPRSS4-mediated/JJ
EMT/NN
and/CC
invasion/NN
in/IN
colon/NN
cancer/NN
cells/NNS
but/CC
was/VBD
not/RB
sufficient/JJ
for/IN
induction/NN
of/IN
these/DT
phenotypes/NNS
[/(
35/CD
]/)
,/,
suggesting/VBG
that/IN
downregulation/NN
of/IN
E-cadherin/NN
is/VBZ
not/RB
the/DT
sole/JJ
contributor/NN
to/TO
TMPRSS4-mediated/JJ
phenotypes/NNS
./.
====================
In/IN
this/DT
respect/NN
,/,
upregulation/NN
of/IN
specific/JJ
mesenchymal/JJ
markers/NNS
,/,
such/JJ
as/IN
integrin/NN
α5/NN
,/,
besides/VBZ
the/DT
downregulation/NN
of/IN
E-cadherin/NN
by/IN
TMPRSS4/NN
,/,
may/MD
be/VB
required/VBN
for/IN
full/JJ
invasiveness/RB
during/IN
colon/NN
cancer/NN
progression/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
Molecular/JJ
mechanisms/NNS
and/CC
signals/NNS
regulated/VBN
by/IN
TMPRSS4/CD
====================
Numerous/JJ
studies/NNS
have/VBP
focused/VBN
on/IN
the/DT
investigation/NN
of/IN
in/FW
vivo/FW
substrates/NNS
of/IN
TTSPs/NNS
./.
====================
However/RB
,/,
few/JJ
studies/NNS
have/VBP
conclusively/RB
addressed/VBN
the/DT
in/FW
vivo/FW
molecular/JJ
targets/NNS
and/CC
function/NN
of/IN
TTSPs/NNS
during/IN
tumor/NN
progression/NN
./.
====================
In/IN
vitro/FW
,/,
several/JJ
TTSPs/NNS
,/,
including/VBG
matriptase/NN
,/,
were/VBD
shown/VBN
to/TO
activate/VB
prourokinase/NN
plasminogen/NN
activator/NN
,/,
pro-macrophage/JJ
stimulating/VBG
protein-1/NN
,/,
and/CC
pro-HGF/NN
,/,
which/WDT
are/VBP
implicated/VBN
in/IN
the/DT
proliferation/NN
,/,
migration/NN
and/CC
invasion/NN
of/IN
various/JJ
cancer/NN
cell/NN
types/NNS
[/(
23/CD
]/)
./.
====================
Like/IN
most/JJS
of/IN
the/DT
members/NNS
of/IN
the/DT
TTSP/NN
family/NN
,/,
TMPRSS4/NN
can/MD
activate/VB
epithelial/JJ
sodium/NN
channel/NN
(/(
ENaC/NN
)/)
in/IN
vitro/FW
through/IN
its/PRP$
proteolytic/JJ
activity/NN
,/,
possibly/RB
regulating/VBG
sodium/NN
and/CC
water/NN
flux/NN
across/IN
high-resistance/RB
epithelia/NN
[/(
48/CD
,/,
49/CD
]/)
./.
====================
TMPRSS4/CD
induces/VBZ
cancer/NN
cell/NN
invasion/NN
in/IN
a/DT
manner/NN
that/IN
is/VBZ
dependent/JJ
on/IN
serine/NN
proteolytic/JJ
activity/NN
[/(
38/CD
]/)
,/,
and/CC
inhibitory/JJ
compounds/NNS
against/IN
TMPRSS4/NN
serine/NN
protease/NN
activity/NN
were/VBD
reported/VBN
to/TO
reduce/VB
colon/NN
cancer/NN
cell/NN
invasion/NN
[/(
50/CD
]/)
./.
====================
However/RB
,/,
it/PRP
remains/VBZ
unknown/JJ
which/WDT
precursor/NN
substrates/NNS
are/VBP
cleaved/VBN
by/IN
TMPRSS4/NN
to/TO
contribute/VB
to/TO
tumor/NN
progression/NN
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
it/PRP
has/VBZ
recently/RB
been/VBN
reported/VBN
that/IN
TMPRSS4/NN
induces/VBZ
urokinase/JJ
plasminogen/NN
activator/NN
(/(
uPA/NN
)/)
gene/NN
expression/NN
through/IN
activation/NN
of/IN
the/DT
transcription/NN
factors/NNS
AP-1/NN
,/,
Sp1/NN
,/,
and/CC
Sp3/NN
in/IN
mainly/RB
a/DT
JNK-dependent/JJ
manner/NN
in/IN
prostate/NN
and/CC
lung/NN
cancer/NN
cells/NNS
but/CC
not/RB
in/IN
colon/NN
cancer/NN
cells/NNS
[/(
44/CD
]/)
./.
====================
uPA/RB
is/VBZ
a/DT
well-known/JJ
serine/NN
protease/NN
involved/VBN
in/IN
invasion/NN
and/CC
metastasis/NN
and/CC
correlates/VBZ
with/IN
poor/JJ
prognosis/NN
in/IN
breast/NN
,/,
lung/NN
,/,
stomach/DT
,/,
bladder/RB
,/,
colon/NN
,/,
prostate/NN
,/,
and/CC
ovarian/JJ
cancers/NNS
[/(
51/CD
]/)
,/,
and/CC
TMPRSS4/NN
expression/NN
significantly/RB
correlates/VBZ
with/IN
uPA/NN
expression/NN
in/IN
human/JJ
lung/NN
and/CC
prostate/NN
adenocarcinomas/NNS
[/(
44/CD
]/)
./.
====================
In/IN
addition/NN
,/,
TMPRSS4-mediated/JJ
uPA/NN
expression/NN
contributes/VBZ
to/TO
prostate/VB
cancer/NN
cell/NN
invasion/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
[/(
44/CD
]/)
./.
====================
It/PRP
is/VBZ
intriguing/JJ
that/DT
TMPRSS4/NN
activates/VBZ
JNK/NN
signaling/NN
pathways/NNS
,/,
possibly/RB
through/IN
its/PRP$
association/NN
with/IN
uPAR/NN
,/,
leading/VBG
to/TO
uPA/VB
expression/NN
./.
====================
uPAR/NN
can/MD
induce/VB
the/DT
EMT/NN
and/CC
stem/NN
cell-like/JJ
properties/NNS
in/IN
breast/NN
cancer/NN
cells/NNS
by/IN
activating/VBG
diverse/JJ
cell/NN
signaling/NN
pathways/NNS
,/,
including/VBG
ERK/NN
,/,
phosphoinositide-3-kinase-Akt/NN
,/,
and/CC
Rac1/NN
[/(
45/CD
,/,
52/CD
]/)
./.
====================
Therefore/RB
,/,
the/DT
association/NN
of/IN
TMPRSS4/NN
and/CC
uPAR/NN
and/CC
subsequent/JJ
cell/NN
signaling/NN
modulation/NN
may/MD
be/VB
a/DT
novel/JJ
mechanism/NN
for/IN
the/DT
control/NN
of/IN
invasion/NN
and/CC
the/DT
EMT/NN
./.
====================
The/DT
observations/NNS
that/IN
TMPRSS4/NN
modulates/VBZ
cell/NN
signaling/NN
and/CC
subsequently/RB
activates/VBZ
both/CC
AP-1/NN
and/CC
Sp1/3/NN
transcriptional/JJ
activities/NNS
[/(
44/CD
]/)
,/,
which/WDT
have/VBP
been/VBN
reported/VBN
to/TO
be/VB
involved/VBN
in/IN
the/DT
transcriptional/JJ
regulation/NN
of/IN
the/DT
EMT/NN
and/CC
invasion/NN
[/(
53/CD
]/)
,/,
suggest/VBP
that/IN
TMPRSS4/NN
could/MD
modulate/VB
the/DT
expression/NN
of/IN
various/JJ
genes/NNS
,/,
which/WDT
may/MD
be/VB
associated/VBN
with/IN
invasion/NN
and/CC
metastasis/NN
./.
====================
The/DT
tetraspanins/NNS
====================
Tetraspanins/NNS
(/(
TM4SFs/NNS
)/)
have/VBP
four/CD
transmembrane/JJ
protein/NN
domains/NNS
with/IN
two/CD
extracellular/JJ
loops/NNS
and/CC
one/CD
intracellular/JJ
loop/NN
(/(
ICL/NN
)/)
and/CC
the/DT
N-/NN
and/CC
C-terminal/JJ
tails/NNS
[/(
54/CD
]/)
./.
====================
They/PRP
are/VBP
expressed/VBN
on/IN
the/DT
cell/NN
surface/NN
and/or/CC
intracellular/JJ
vesicles/NNS
and/CC
contain/VBP
33/CD
members/NNS
in/IN
mammals/NNS
[/(
55/CD
]/)
./.
====================
Tetraspanins/NNS
,/,
or/CC
TM4SFs/NNS
,/,
are/VBP
suggested/VBN
to/TO
be/VB
located/JJ
at/IN
tetraspanin-enriched/VBN
microdomains/NNS
(/(
TERMs/NNS
)/)
[/(
56/CD
]/)
,/,
where/WRB
they/PRP
form/VBP
protein-protein/JJ
complexes/NNS
in/IN
a/DT
homophilic/JJ
or/CC
heterophilic/JJ
manner/NN
with/IN
other/JJ
TM4SFs/NNS
,/,
integrins/NNS
,/,
or/CC
growth/NN
factor/NN
receptors/NNS
[/(
57/CD
,/,
58/CD
]/)
./.
====================
The/DT
protein/NN
complexes/NNS
are/VBP
known/VBN
to/TO
regulate/VB
the/DT
dynamics/NNS
of/IN
the/DT
complex/NN
components/NNS
on/IN
the/DT
cell/NN
surface/NN
with/IN
regard/NN
to/TO
diffusion/NN
,/,
trafficking/VBG
,/,
retention/NN
,/,
and/CC
stability/NN
,/,
in/IN
addition/NN
to/TO
influencing/VBG
intracellular/JJ
signal/NN
transductions/NNS
[/(
56/CD
,/,
59/CD
,/,
60/CD
]/)
./.
====================
TM4SF5/NN
in/IN
cancer/NN
====================
TM4SF5/NN
(/(
gene/NN
ID/NN
,/,
9032/CD
)/)
maps/VBZ
to/TO
chromosome/NN
17/CD
at/IN
17p13.3/NN
according/VBG
to/TO
Entrez/NN
Gene/NN
./.
====================
In/IN
AceView/NN
,/,
it/PRP
covers/VBZ
11.34/CD
kb/NN
,/,
from/IN
4621928/CD
to/TO
4633262/CD
(/(
NCBI/NN
36/CD
,/,
March/NNP
2006/CD
)/)
,/,
on/IN
the/DT
direct/JJ
strand/NN
containing/VBG
4/CD
different/JJ
gt-ag/NN
introns/NNS
./.
====================
Its/PRP$
transcription/NN
produces/VBZ
2/CD
alternatively/RB
spliced/VBN
mRNAs/NNS
via/IN
alternative/JJ
polyadenylation/NN
sites/NNS
,/,
which/WDT
putatively/RB
encode/VBP
2/CD
different/JJ
isoforms/NNS
(/(
197/CD
and/CC
132/CD
amino/NN
acids/NNS
)/)
,/,
containing/VBG
an/DT
L6/NN
membrane/NN
domain/NN
(/(
http/NN
:/:
//www.ncbi.nlm.nih.gov/IEB/Research/Acembly/av.cgi/NNP
?/.
db=35g/IN
&/CC
c=Gene/NN
&/CC
l=TM4SF5/NN
)/)
./.
====================
TM4SF5/CD
(/(
20,823/CD
Da/NN
)/)
is/VBZ
a/DT
transmembrane/JJ
glycoprotein/NN
;/:
as/IN
a/DT
family/NN
group/NN
,/,
it/PRP
is/VBZ
related/JJ
to/TO
the/DT
tetraspanin/NN
family/NN
(/(
transmembrane/JJ
4/CD
L/NN
six/CD
family/NN
)/)
,/,
including/VBG
TM4SF1/NN
(/(
L6/NN
,/,
L6-Ag/NNP
)/)
,/,
TM4SF4/NN
(/(
IL-TIMP/NN
)/)
,/,
TM4SF518/NN
(/(
L6D/NN
)/)
,/,
and/CC
TM4SF20/NN
[/(
61/CD
,/,
62/CD
]/)
./.
====================
TM4SF5/NN
is/VBZ
highly/RB
expressed/VBN
in/IN
diverse/JJ
types/NNS
of/IN
cancers/NNS
,/,
including/VBG
liver/NN
,/,
pancreatic/JJ
,/,
gastric/JJ
,/,
colon/NN
,/,
adrenocorticotropic/JJ
hormone/NN
(/(
corticotropin/NN
)/)
-negative/JJ
bronchial/JJ
carcinoid/JJ
tumors/NNS
,/,
soft-tissue/RB
sarcoma/NN
,/,
nonendocrine/JJ
lung/NN
,/,
and/CC
papilla/NN
vateri/FW
carcinoma/NN
[/(
63/CD
,/,
64/CD
,/,
65/CD
,/,
66/CD
]/)
./.
====================
Similar/JJ
to/TO
tetraspanins/NNS
(/(
i.e./FW
,/,
transmembrane/JJ
4/CD
superfamily/RB
,/,
TM4SFs/NNS
)/)
,/,
TM4SF5/NN
has/VBZ
four/CD
transmembrane/JJ
domains/NNS
(/(
TM1-TM4/NN
)/)
,/,
short/JJ
cytoplasmic/JJ
domains/NNS
at/IN
their/PRP$
N-/JJ
and/CC
C-termini/NN
,/,
an/DT
ICL/NN
between/IN
TM2/NN
and/CC
TM4/NN
,/,
two/CD
extracellular/JJ
loops/NNS
,/,
a/DT
smaller/JJR
extracellular/JJ
loop/NN
between/IN
TM1/NN
and/CC
TM2/NN
,/,
and/CC
a/DT
larger/RBR
extracellular/JJ
loop/NN
between/IN
TM3/NN
and/CC
TM4/NN
[/(
61/CD
,/,
62/CD
]/)
./.
====================
Recent/JJ
clinical/JJ
studies/NNS
separately/RB
report/VBP
that/IN
TM4SF5/NN
is/VBZ
highly/RB
expressed/VBN
in/IN
tumors/NNS
from/IN
deceased/VBN
breast/NN
cancer/NN
patients/NNS
,/,
compared/VBN
to/TO
those/DT
from/IN
10-year/JJ
breast/NN
cancer/NN
survivors/NNS
[/(
67/CD
]/)
,/,
and/CC
that/IN
postoperative/JJ
5-year/JJ
overall/JJ
survival/NN
of/IN
esophageal/JJ
cancer/NN
patients/NNS
negatively/RB
correlates/VBZ
with/IN
TM4SF5/NN
expression/NN
[/(
68/CD
]/)
./.
====================
These/DT
reports/NNS
suggest/VBP
that/IN
TM4SF5/NN
overexpression/NN
correlates/VBZ
with/IN
poor/JJ
prognosis/NN
of/IN
cancer/NN
patients/NNS
./.
====================
TM4SF5-mediated/JJ
regulation/NN
of/IN
signaling/NN
molecules/NNS
====================
TM4SF5/NN
can/MD
appear/VB
to/TO
form/VB
TERMs/NNS
on/IN
the/DT
cell/NN
surface/NN
,/,
via/IN
formation/NN
of/IN
large/JJ
protein-protein/JJ
complexes/NNS
with/IN
tetraspanins/NNS
,/,
integrins/NNS
,/,
and/CC
growth/NN
factor/NN
receptors/NNS
[/(
61/CD
,/,
69/CD
]/)
./.
====================
Therefore/RB
,/,
by/IN
virtue/NN
of/IN
the/DT
protein/NN
complex/NN
formation/NN
,/,
overexpressed/VBN
TM4SF5/NN
in/IN
cancer/NN
cells/NNS
can/MD
influence/VB
or/CC
activate/VBP
diverse/JJ
intracellular/JJ
signaling/VBG
pathways/NNS
for/IN
cell/NN
adhesion/NN
,/,
proliferation/NN
,/,
the/DT
EMT/NN
,/,
migration/NN
,/,
and/CC
invasion/NN
for/IN
tumor/NN
progression/NN
and/CC
maintenance/NN
./.
====================
TM4SF5/DT
is/VBZ
shown/VBN
to/TO
associate/VB
with/IN
integrins/NNS
α2/NN
,/,
β1/RB
[/(
70/CD
,/,
71/CD
]/)
,/,
α5/RB
[/(
72/CD
]/)
,/,
and/CC
epidermal/JJ
growth/NN
factor/NN
receptor/NN
(/(
EGFR/NN
)/)
[/(
73/CD
,/,
74/CD
]/)
during/IN
cell/NN
migration/NN
[/(
70/CD
,/,
71/CD
]/)
,/,
angiogenesis/NN
[/(
72/CD
]/)
,/,
drug/NN
resistance/NN
[/(
74/CD
]/)
,/,
and/CC
fibrosis/NN
[/(
73/CD
]/)
./.
====================
With/IN
association/NN
and/CC
retention/NN
of/IN
integrin/NN
α5/NN
on/IN
the/DT
cell/NN
surface/NN
,/,
TM4SF5/NN
can/MD
activate/VB
intracellular/JJ
signaling/VBG
for/IN
FAK/c-Src/NN
activation/NN
,/,
leading/VBG
to/TO
STAT3/NN
activity/NN
for/IN
vascular/JJ
endothelial/JJ
growth/NN
factor/NN
(/(
VEGF/NN
)/)
induction/NN
[/(
72/CD
]/)
./.
====================
In/IN
addition/NN
,/,
TM4SF5/NN
directly/RB
interacts/VBZ
with/IN
FAK/NN
or/CC
c-Src/NN
to/TO
regulate/VB
migration/NN
[/(
75/CD
]/)
and/CC
invasive/JJ
ECM/NN
degradation/NN
[/(
76/CD
]/)
./.
====================
In/IN
addition/NN
,/,
TM4SF5/NN
expression/NN
causes/VBZ
AKT/NN
activation/NN
,/,
which/WDT
in/IN
turn/NN
causes/VBZ
phosphorylation/NN
of/IN
p27Kip1/NN
Ser10/NN
for/IN
its/PRP$
cytosolic/JJ
translocation/NN
,/,
where/WRB
it/PRP
can/MD
regulate/VB
RhoA/NN
activity/NN
for/IN
morphological/JJ
change/NN
and/CC
migratory/JJ
function/NN
[/(
74/CD
]/)
./.
====================
TM4SF5-mediated/JJ
EMT/NN
in/IN
tumor/NN
progression/NN
====================
TM4SF5/NN
expression/NN
in/IN
hepatocytes/NNS
or/CC
NSCLC/NN
leads/VBZ
to/TO
EMT/NN
phenotypes/NNS
,/,
which/WDT
in/IN
turn/NN
cause/VBP
loss/NN
of/IN
contact/NN
inhibition/NN
[/(
74/CD
]/)
,/,
enhance/VBP
migration/NN
and/CC
invasion/NN
for/IN
metastasis/NN
[/(
77/CD
]/)
,/,
and/CC
render/VBP
gefitinib/NN
resistance/NN
[/(
78/CD
]/)
./.
====================
TM4SF5/NN
expression/NN
causes/VBZ
morphological/JJ
changes/NNS
through/IN
abnormal/JJ
regulation/NN
of/IN
RhoA/NN
and/CC
Rac1/NN
in/IN
hepatocytes/NNS
,/,
together/RB
with/IN
the/DT
loss/NN
of/IN
E-cadherin/NN
expression/NN
leading/VBG
to/TO
EMT/NN
induction/NN
[/(
74/CD
]/)
via/IN
induction/NN
of/IN
Slug/NN
[/(
79/CD
]/)
./.
====================
Inhibition/NN
of/IN
TM4SF5-mediated/JJ
signaling/NN
events/NNS
of/IN
the/DT
cytosolic/JJ
enrichment/JJ
of/IN
p27Kip1/NN
abolishes/VBZ
abnormal/JJ
multilayer/JJ
cell/NN
growth/NN
[/(
74/CD
]/)
and/CC
retards/VBZ
the/DT
G1/NN
to/TO
S/NN
phase/NN
progression/NN
[/(
80/CD
]/)
./.
====================
Further/RB
,/,
inhibition/NN
of/IN
TM4SF5-mediated/JJ
EMT/NN
by/IN
suppression/NN
of/IN
cytosolic/JJ
p27Kip1/NN
expression/NN
leads/VBZ
gefitinib-resistant/JJ
NSCLC/NN
cells/NNS
to/TO
become/VB
gefitinib-sensitive/JJ
[/(
78/CD
]/)
./.
====================
TM4SF5/NN
is/VBZ
involved/VBN
in/IN
activation/NN
of/IN
hepatic/JJ
stellate/JJ
cells/NNS
by/IN
causing/VBG
EMT/NN
processes/NNS
,/,
leading/VBG
to/TO
a/DT
correlation/NN
with/IN
the/DT
development/NN
of/IN
liver/NN
fibrosis/NN
in/IN
CCl4-treated/JJ
mouse/NN
models/NNS
[/(
81/CD
]/)
./.
====================
TM4SF5/NN
expression/NN
is/VBZ
achieved/VBN
by/IN
TGFβ1-mediated/JJ
Smad/JJ
actions/NNS
on/IN
EGFR/NN
activation/NN
[/(
73/CD
]/)
,/,
such/JJ
that/IN
the/DT
important/JJ
roles/NNS
of/IN
the/DT
multifunctional/JJ
cytokine/NN
TGFβ1/NN
in/IN
the/DT
activation/NN
of/IN
hepatic/JJ
stellate/JJ
cells/NNS
and/CC
the/DT
EMT/NN
are/VBP
confirmed/VBN
in/IN
a/DT
development/NN
of/IN
murine/JJ
liver/NN
fibrosis/NN
./.
====================
Since/IN
liver/NN
fibrosis/NN
can/MD
eventually/RB
lead/VBP
to/TO
hepatocarcinoma/NN
at/IN
a/DT
high/JJ
rate/NN
of/IN
over/IN
70/CD
%/NN
[/(
82/CD
]/)
,/,
the/DT
roles/NNS
of/IN
TM4SF5/NN
in/IN
the/DT
development/NN
of/IN
both/DT
fibrosis/NN
and/CC
tumorigenesis/NN
in/IN
the/DT
liver/NN
can/MD
be/VB
reasonable/JJ
./.
====================
Meanwhile/DT
,/,
TM4SF5/NN
expression/NN
enhances/VBZ
directional/JJ
migration/NN
and/CC
invasion/NN
of/IN
hepatocytes/NNS
./.
====================
TM4SF5/NN
in/IN
hepatocytes/NNS
causes/VBZ
directional/JJ
migration/NN
at/IN
an/DT
enhanced/VBN
speed/RB
and/CC
the/DT
formation/NN
of/IN
more/RBR
invadosome-like/JJ
structures/NNS
enriched/JJ
with/IN
cortactin/NN
,/,
actin/NN
,/,
and/CC
actin-regulatory/JJ
proteins/NNS
,/,
like/IN
Arp2/NN
and/CC
WASP/NN
[/(
77/CD
]/)
./.
====================
TM4SF5-mediated/JJ
directional/JJ
migration/NN
involves/VBZ
direct/JJ
interaction/NN
and/CC
activation/NN
of/IN
FAK/NN
via/IN
the/DT
ICL/NN
domain/NN
of/IN
TM4SF5/NN
and/CC
the/DT
F1/NN
lobe/NN
of/IN
the/DT
FAK/NN
FERM/NN
domain/NN
[/(
75/CD
]/)
./.
====================
Further/RB
,/,
TM4SF5-mediated/JJ
invasive/JJ
ECM/NN
degradation/NN
requires/VBZ
direct/JJ
interaction/NN
between/IN
the/DT
COOH-terminus/JJ
of/IN
TM4SF5/NN
and/CC
c-Src/NN
,/,
which/WDT
is/VBZ
linked/VBN
to/TO
Tyr845/NN
phosphorylation/NN
of/IN
EGFR/NN
to/TO
form/VB
more/RBR
invasive/JJ
protrusions/NNS
[/(
76/CD
]/)
./.
====================
TM4SF5-mediated/JJ
multilayer/JJ
growth/NN
[/(
74/CD
]/)
,/,
FAK/NN
activity/NN
,/,
migration/NN
,/,
and/CC
invasion/NN
[/(
75/CD
]/)
are/VBP
abolished/VBN
by/IN
an/DT
anti-TM4SF5/JJ
reagent/JJ
,/,
TSAHC/NN
(/(
a/DT
synthetic/JJ
compound/NN
)/)
,/,
which/WDT
appears/VBZ
to/TO
affect/VB
its/PRP$
N-glycosylation/NN
and/CC
at/IN
the/DT
same/JJ
time/NN
block/VBP
induction/NN
of/IN
the/DT
TM4SF5-dependent/JJ
EMT/NN
phenotype/NN
and/CC
multilayer/JJ
growth/NN
[/(
83/CD
]/)
./.
====================
Therefore/RB
,/,
TM4SF5/NN
also/RB
plays/VBZ
important/JJ
roles/NNS
in/IN
tumor/NN
initiation/NN
and/CC
progression/NN
,/,
possibly/RB
being/VBG
supported/VBN
by/IN
an/DT
EMT/NN
process/NN
./.
====================
Other/JJ
TM4SF5-mediated/JJ
EMT-related/JJ
biological/JJ
processes/NNS
====================
The/DT
EMT/NN
is/VBZ
well/RB
known/VBN
to/TO
be/VB
related/JJ
also/RB
to/TO
the/DT
development/NN
[/(
84/CD
]/)
and/CC
stemness/JJ
of/IN
self-renewal/JJ
[/(
9/CD
]/)
./.
====================
We/PRP
also/RB
observed/VBN
that/IN
TM4SF5/NN
can/MD
play/VB
roles/NNS
in/IN
other/JJ
EMT-mediated/JJ
biological/JJ
processes/NNS
,/,
like/IN
development/NN
of/IN
muscles/NNS
and/CC
self-renewal/JJ
of/IN
cancer/NN
cells/NNS
./.
====================
In/IN
zebrafish/NN
,/,
suppression/NN
of/IN
tm4sf5/NN
results/NNS
in/IN
abnormal/JJ
development/NN
,/,
with/IN
an/DT
aberrant/JJ
trunk/NN
and/CC
morphology/NN
of/IN
muscle/NN
fibers/NNS
,/,
presumably/RB
via/IN
alterations/NNS
in/IN
the/DT
expression/NN
and/CC
localization/NN
of/IN
integrin/NN
α5/NN
,/,
which/WDT
is/VBZ
necessary/JJ
for/IN
somite/RB
boundary/RB
maintenance/NN
(/(
Choi/NNP
YJ/NN
and/CC
Lee/NNP
JW/NN
,/,
in/IN
revision/NN
)/)
./.
====================
In/IN
addition/NN
to/TO
liver/NN
fibrosis/NN
and/CC
tumorigenesis/NN
,/,
therefore/RB
,/,
TM4SF5/NN
expression/NN
is/VBZ
importantly/RB
involved/VBN
in/IN
the/DT
development/NN
of/IN
zebrafish/NN
muscles/NNS
,/,
which/WDT
might/MD
bemediated/VBN
by/IN
EMT/NN
./.
====================
Presumably/RB
,/,
these/DT
diverse/JJ
cellular/JJ
effects/NNS
by/IN
TM4SF5/NN
expression/NN
might/MD
be/VB
possible/JJ
due/JJ
to/TO
the/DT
characteristics/NNS
of/IN
TM4SF5-similar/JJ
to/TO
tetraspanins-which/JJ
forms/NNS
large/JJ
protein/NN
networks/NNS
via/IN
heterophilic/JJ
or/CC
homophilic/JJ
interactions/NNS
between/IN
tetraspanins/NNS
,/,
integrins/NNS
,/,
and/CC
growth/NN
factor/NN
receptors/NNS
./.
====================
TM4SF5/NN
is/VBZ
shown/VBN
to/TO
bind/VB
integrin/NN
α2/NN
,/,
β1/NN
[/(
70/CD
,/,
71/CD
]/)
,/,
α5/RB
[/(
72/CD
]/)
,/,
EGFR/NN
[/(
73/CD
]/)
,/,
and/CC
interleukin/NN
6/CD
receptor/NN
(/(
IL6R/NN
)/)
(/(
Ryu/NNP
J/NN
and/CC
Lee/NNP
JW/NN
,/,
in/IN
revision/NN
)/)
./.
====================
Although/IN
its/PRP$
ligand/NN
has/VBZ
not/RB
been/VBN
identified/VBN
,/,
interaction/NN
(/(
s/NNS
)/)
with/IN
(/(
an/DT
)/)
other/JJ
membrane/NN
protein/NN
or/CC
receptor/NN
can/MD
recapitulate/VB
the/DT
ligand/NN
binding-based/VBD
activation/NN
./.
====================
Therefore/RB
,/,
TM4SF5/NN
can/MD
transduce/VB
signaling/NN
activities/NNS
for/IN
diverse/JJ
cellular/JJ
functions/NNS
,/,
including/VBG
the/DT
EMT/NN
and/CC
different/JJ
EMT-mediated/JJ
phenotypes/NNS
./.
====================
Although/IN
diverse/JJ
miRs/NNS
are/VBP
known/VBN
to/TO
regulate/VB
the/DT
EMT/NN
[/(
7/CD
]/)
,/,
miRs/NNS
targeting/VBG
TM4SF5/NN
are/VBP
being/VBG
studied/VBN
./.
====================
TM4SF5-mediated/JJ
gene/NN
regulation/NN
====================
Comparison/NN
of/IN
protein/NN
expression/NN
patterns/NNS
between/IN
TM4SF5-null/JJ
and/CC
-expressing/JJ
cells/NNS
shows/VBZ
a/DT
negative/JJ
correlation/NN
between/IN
TM4SF5/NN
and/CC
cell-cell/JJ
adhesion-related/JJ
molecules/NNS
of/IN
epithelial/JJ
markers/NNS
,/,
including/VBG
E-cadherin/NN
[/(
74/CD
]/)
,/,
and/CC
a/DT
positive/JJ
correlation/NN
between/IN
TM4SF5/NN
and/CC
mesenchymal/JJ
markers/NNS
,/,
including/VBG
Slug/NN
[/(
79/CD
]/)
,/,
supporting/VBG
TM4SF5-mediated/JJ
EMT/NN
./.
====================
Reverse/JJ
transcription/NN
polymerase/NN
chain/NN
reaction/NN
analyses/NNS
of/IN
show/VBP
that/IN
TM4SF5-mediated/JJ
regulation/NN
of/IN
their/PRP$
expressions/NNS
occurs/VBZ
at/IN
the/DT
transcriptional/JJ
level/NN
(/(
Lee/NNP
JW/NN
,/,
unpublished/JJ
observation/NN
)/)
./.
====================
However/RB
,/,
the/DT
signaling/NN
pathways/NNS
underlying/VBG
this/DT
regulation/NN
have/VBP
not/RB
been/VBN
determined/VBN
yet/RB
./.
====================
In/IN
addition/NN
,/,
TM4SF5/NN
expression/NN
also/RB
correlates/VBZ
with/IN
cytosolic/JJ
p27Kip1/NN
[/(
74/CD
]/)
./.
====================
Although/IN
p27Kip1/NN
in/IN
the/DT
nucleus/NN
is/VBZ
inhibitory/JJ
to/TO
cyclin-dependent/JJ
kinases/NNS
,/,
suppressing/VBG
the/DT
cell/NN
cycle/NN
and/CC
proliferation/NN
,/,
its/PRP$
localization/NN
in/IN
the/DT
cytosol/NN
can/MD
lead/VB
to/TO
tumorigenic/JJ
functions/NNS
[/(
85/CD
]/)
./.
====================
Cytosolic/JJ
p27Kip1/NN
has/VBZ
been/VBN
reported/VBN
in/IN
different/JJ
clinical/JJ
reports/NNS
,/,
where/WRB
different/JJ
cancer/NN
types/NNS
show/VBP
enriched/JJ
cytosolic/JJ
localization/NN
of/IN
p27Kip1/NN
[/(
86/CD
,/,
87/CD
,/,
88/CD
]/)
,/,
suggesting/VBG
that/IN
cytosolic/JJ
p27Kip1/NN
can/MD
be/VB
tumorigenic/JJ
[/(
89/CD
]/)
./.
====================
p27Kip1/NN
can/MD
be/VB
phosphorylated/VBN
by/IN
Akt/NN
,/,
KIS/NN
,/,
or/CC
JNK/NN
[/(
90/CD
,/,
91/CD
,/,
92/CD
]/)
,/,
resulting/VBG
in/IN
translocalization/NN
and/CC
stabilization/NN
in/IN
the/DT
cytosol/NN
,/,
where/WRB
it/PRP
binds/VBZ
to/TO
and/CC
inactivates/VBZ
RhoA/NN
GTPase/NN
,/,
leading/VBG
to/TO
alterations/NNS
in/IN
actin/NN
organization/NN
and/CC
motility/NN
regulation/NN
[/(
93/CD
]/)
./.
====================
TM4SF5/NN
expression/NN
also/RB
causes/VBZ
overexpression/NN
of/IN
p27Kip1/NN
,/,
although/IN
how/WRB
it/PRP
occurs/VBZ
is/VBZ
unknown/JJ
;/:
TM4SF5/NN
causes/VBZ
Akt-mediated/JJ
Ser10/NN
phosphorylation/NN
of/IN
p27Kip1/NN
,/,
leading/VBG
to/TO
its/PRP$
stabilization/NN
,/,
RhoA/NN
activity/NN
changes/NNS
,/,
and/CC
eventually/RB
morphological/JJ
elongation/NN
for/IN
the/DT
EMT/NN
and/CC
contact/NN
inhibition/NN
loss/NN
[/(
74/CD
]/)
./.
====================
JNK-mediated/JJ
p27Kip1/NN
phosphorylation/NN
in/IN
a/DT
TM4SF5-dependent/JJ
manner/NN
also/RB
results/VBZ
in/IN
localization/NN
of/IN
p27Kip1/NN
at/IN
cell-cell/JJ
contacts/NNS
[/(
91/CD
]/)
,/,
possibly/RB
leading/VBG
to/TO
altered/JJ
actin/NN
organization/NN
at/IN
cell-cell/JJ
contacts/NNS
./.
====================
In/IN
addition/NN
,/,
inhibition/NN
of/IN
the/DT
proteasome/NN
in/IN
terms/NNS
of/IN
activity/NN
and/CC
subunit/NN
expression/NN
also/RB
depends/VBZ
on/IN
TM4SF5/NN
expression/NN
,/,
resulting/VBG
in/IN
morphological/JJ
changes/NNS
and/CC
the/DT
EMT/NN
,/,
suggesting/VBG
another/DT
novel/JJ
mechanism/NN
for/IN
TM4SF5-mediated/JJ
EMT/NN
[/(
79/CD
]/)
./.
====================
Meanwhile/DT
,/,
TM4SF5/NN
causes/VBZ
activation/NN
of/IN
the/DT
FAK/c-Src/NN
signaling/NN
pathways/NNS
,/,
leading/VBG
to/TO
STAT3/NN
phosphorylation/NN
at/IN
Tyr705/NN
for/IN
the/DT
induction/NN
and/CC
secretion/NN
of/IN
VEGF/NN
,/,
which/WDT
can/MD
stimulate/VB
neighboring/JJ
endothelial/JJ
cells/NNS
for/IN
enhanced/VBN
(/(
tumor/NN
)/)
angiogenesis/NN
[/(
72/CD
]/)
./.
====================
During/IN
modeling/VBG
of/IN
the/DT
tumor/NN
microenvironment/NN
,/,
cancer/NN
cells/NNS
overexpressing/VBG
TM4SF5/NN
appear/VBP
to/TO
negatively/RB
regulate/VBP
expression/NN
of/IN
the/DT
cytokine/NN
IL6/NN
,/,
and/CC
exogenous/JJ
IL6/NN
treatment/NN
leads/VBZ
to/TO
less/RBR
STAT3/NN
signaling/VBG
activation/NN
in/IN
TM4SF5-positive/JJ
cancer/NN
cells/NNS
(/(
Ryu/NNP
J/NNP
and/CC
Lee/NNP
JW/NN
,/,
in/IN
revision/NN
)/)
;/:
thus/RB
,/,
TM4SF5-dependent/JJ
suppression/NN
of/IN
IL6/NN
can/MD
be/VB
a/DT
strategy/NN
for/IN
TM4SF5-positive/JJ
tumor/NN
cells/NNS
to/TO
avoid/VB
pro-immunological/JJ
actions/NNS
by/IN
IL6/NN
secreted/VBN
by/IN
neighboring/VBG
immune/JJ
cells/NNS
./.
====================
As/IN
for/IN
invasion/NN
,/,
TM4SF5/NN
expression/NN
also/RB
increases/VBZ
the/DT
mRNA/NN
and/CC
protein/NN
levels/NNS
of/IN
MMP2/NN
,/,
in/IN
addition/NN
to/TO
its/PRP$
activity/NN
[/(
77/CD
]/)
./.
====================
Therefore/RB
,/,
TM4SF5/NN
expression/NN
correlates/VBZ
with/IN
or/CC
plays/VBZ
important/JJ
roles/NNS
in/IN
tumorigenesis/NN
in/IN
different/JJ
mechanisms/NNS
,/,
including/VBG
induction/NN
of/IN
the/DT
EMT/NN
and/CC
gene/NN
regulation/NN
(/(
Fig/NN
./.
====================
2/CD
)/)
./.
====================
Considering/VBG
that/DT
such/JJ
membrane/NN
proteins/NNS
as/IN
TMPRSS4/NN
or/CC
TM4SF5/NN
may/MD
be/VB
important/JJ
upstream/RB
regulators/NNS
of/IN
the/DT
EMT/NN
and/CC
the/DT
invasiveness/NN
of/IN
cancer/NN
cells/NNS
and/CC
because/IN
their/PRP$
expression/NN
differs/VBZ
substantially/RB
in/IN
normal/JJ
and/CC
cancer/NN
tissues/NNS
,/,
targeting/VBG
them/PRP
could/MD
be/VB
a/DT
novel/JJ
therapeutic/JJ
strategy/NN
for/IN
the/DT
treatment/NN
of/IN
cancer/NN
metastasis/NN
./.
====================
In/IN
the/DT
future/JJ
,/,
the/DT
functional/JJ
involvement/NN
of/IN
TMPRSS4/NN
and/or/CC
TM4SF5/NN
in/IN
the/DT
initiation/NN
and/CC
progression/NN
of/IN
tumors/NNS
needs/VBZ
to/TO
be/VB
evaluated/VBN
using/VBG
mouse/NN
models/NNS
./.
====================
Cancer-associated/JJ
mutations/NNS
and/CC
singlenucleotide/JJ
polymorphisms/NNS
within/IN
TMPRSS4/NN
or/CC
TM4SF5/NN
also/RB
need/VBD
to/TO
be/VB
analyzed/VBN
in/IN
association/NN
with/IN
cancer/NN
risk/NN
./.
====================
Cellular/JJ
functions/NNS
of/IN
TMPRSS4/NN
./.
====================
ENaC/NN
,/,
epithelial/JJ
sodium/NN
channel/NN
;/:
uPA/NN
,/,
urokinase/NN
plasminogen/NN
activator/NN
;/:
EMT/NN
,/,
epithelialmesenchymal/JJ
transition/NN
./.
====================
TM4SF5-mediated/JJ
epithelial-mesenchymal/JJ
transition/NN
(/(
EMT/NN
)/)
is/VBZ
involved/VBN
in/IN
diverse/JJ
cellular/JJ
functions/NNS
,/,
leading/VBG
to/TO
liver/NN
tumorigenesis/NN
and/CC
maintenance/NN
in/IN
addition/NN
to/TO
developmental/JJ
processes/NNS
./.
====================
